Price movement over the last 24 hours
Across Protocol vs Symbiosis — how do they compare? Across Protocol trades at Rp757.89 (market cap Rp531,64M, Rp28,19M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Across Protocol is far larger — about 15.6× Symbiosis's market cap, and Across Protocol 's circulating supply is 704,7M / 1B ACX (71%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 54 Days and Symbiosis for 11 Days on average.
| ACX | SIS | |
|---|---|---|
Market Cap | Rp531,64M | Rp34,08M |
Volume (24h) | Rp28,19M | Rp2,71M |
Circulating Supply | 704,7M / 1B ACX (71%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 54 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp741.83 with a bearish technical signal, showing sell pressure from moving averages while oscillators remain neutral. The token is currently testing support near Rp731 with resistance at Rp756. With 71% of the 1 million max supply in circulation and an average hold time of 54 days, the token shows moderate distribution stability despite current bearish momentum.
The overall outlook remains cautious due to strong bearish technical indicators, though neutral oscillators suggest potential stabilization. Key opportunities include protocol utility in cross-chain bridging, while major risks involve low liquidity (Rp522.31M market cap) and crypto market volatility. Investors should monitor support levels for potential entry points.
Symbiosis (SIS) shows limited market activity with a modest market cap of Rp34.08M and near-full circulating supply of 98%. The token exhibits short holding periods averaging 11 days, suggesting speculative trading patterns. No recent protocol updates or significant ecosystem developments were identified, indicating stagnant network growth.
Overall outlook remains cautious due to low liquidity and limited adoption. Key opportunity lies in potential protocol revival, while major risks include extreme volatility and regulatory uncertainty common to low-cap cryptocurrencies.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →